348 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (237)
- Addiction (4)
- Autoimmune Disorders (15)
- Blood Disorders (26)
- Bone & Muscle (1)
- Cancer (4)
- Child Development (1)
- Developmental Disorders (1)
- Endocrine & Metabolic Disease (2)
- Hair and Skin Disorders (2)
- Healthy Volunteers (8)
- Heart Disease (1)
- Liver Disease (1)
- Lung Disease (2)
- Meniere's Disease (1)
- Neurological Disorders (112)
- Obstetrics & Gynecology (3)
- Pediatrics (6)
- Psychiatric Disorders (47)
Displaying 1 - 2 of 2
Condition: Psychiatric Disorders / Schizophrenia
Investigator: Joshua Kantrowitz, Md
Status: Closed
The purpose of this study is to evaluate the efficacy, safety and tolerability of different doses and durations of TV-46000 given by subcutaneous (under the skin) injection as compared to placebo for use as a potential maintenance in adults with schizophrenia.
Condition: Psychiatric Disorders / Schizophrenia
Investigator: Jeffrey Lieberman, MD
Status: Closed
This study plans to learn more about an investigational new drug called lumateperone tosylate (ITI-007) and may help us find new types of treatment for schizophrenia and schizoaffective disorder.
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE